Hartford Financial Management’s 9 Meters Biopharma NMTR Stock Holding History

Hartford Financial Management’s Portfolio NMTR Stock Details NMTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-200	Closed	-$278	–	385
2023 Q1	$278	Hold	200	–	–	﹤0.01%	374
2022 Q4	$252	Buy	+200	New	+$456	﹤0.01%	371
2022 Q3	–	Sell	-200	Closed	-$1K	–	391
2022 Q2	$1K	Hold	200	–	–	﹤0.01%	386
2022 Q1	$2K	Hold	200	–	–	﹤0.01%	376
2021 Q4	$4K	Hold	200	–	–	﹤0.01%	332
2021 Q3	$5K	Hold	200	–	–	﹤0.01%	329
2021 Q2	$4K	Hold	200	–	–	﹤0.01%	342
2021 Q1	$5K	Hold	200	–	–	﹤0.01%	344
2020 Q4	$3K	Hold	200	–	–	﹤0.01%	330
2020 Q3	$3K	Buy	+200	New	+$2.42K	﹤0.01%	305

Other funds holding NMTR

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ODFS

O'Donnell Financial Services San Rafael, California $290M AUM 15.6% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

CIBC Asset Management Toronto, Ontario, Canada $40.9B AUM 35.96% 1-Year Est. Return

Hartford Financial Management's NMTR Position: Q2 2023 in Review

Hartford Financial Management sold out of 9 Meters Biopharma (NMTR) in Q2 2023, closing a stake of 200 shares — an estimated $278 sold.

Hartford Financial Management first reported a position in NMTR in Q3 2020 and held it in 10 quarters. The position peaked at $5K in Q3 2021. 34 funds tracked by Wall St. Rank hold NMTR as of Q2 2023.

Hartford Financial Management reported no remaining 9 Meters Biopharma position as of Q2 2023 after selling out during the quarter.
Hartford Financial Management sold 200 9 Meters Biopharma shares in Q2 2023, an estimated $278.
Hartford Financial Management first reported a position in 9 Meters Biopharma in Q3 2020 and held it in 10 quarters.
Hartford Financial Management's 9 Meters Biopharma position peaked at $5K in Q3 2021.
34 funds tracked by Wall St. Rank held 9 Meters Biopharma as of Q2 2023.

Based on Hartford Financial Management's 13F filing for Q2 2023, filed 27 Jul 2023.